Cite

HARVARD Citation

    Yu, L. et al. (2020). A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma. Cancer biology & therapy. 21 (7), pp. 597-603. [Online]. 
  
Back to record